Screening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA

Size: px
Start display at page:

Download "Screening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA"

Transcription

1 Screening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA

2 I have no relevant Financial Disclosures

3 Agenda Discuss the recent studies calling into question the benefits of mammography. What are the facts and statistics we track Screening recommendations in the general public, special populations, and the importance of breast density

4 RECENT STUDIES CALLING INTO QUESTION THE BENEFITS OF MAMMOGRAPHY

5 UK Independent Review Nordic Cochrane Institute Review US Preventive Services Task Force Review EUROSCREEN Review All of the studies attempted to answer the question how many women need to undergo breast cancer screening, in order to save 1 woman s life, from dying from breast cancer (during the observation time period)? Results varied from 80-2,000

6 Why the large variance? Definition of undergo breast cancer screening Nordic Cochrane Institute Review considered a women being notified and instructed to undergo mammography as being screened. 23% of women didn t show up. During the observational time period Studies ranged from 10 years to 20 years The longer the observational time period, the more efficaous screening mammography became. Which ages were included

7 Nordic Cochrane Institute Review 2,000 women need to get screened to save 1 life. Screening means- getting a reminder Time period- over 10 years Age Change the variables, changes the numbers: 600:1- Screening=mammogram, time frame is 20 years, ages included :1 restrict ages to 50-74

8 The controversy s take home points Screening mammography works- Are the benefits immediate- The benefits can be concentrated- But they shouldn't be

9 FACTS

10 FACT #1 Age is the number one risk factor

11 FACT #2 Must catch it early Prognosis most influenced by axillary node status No nodes- 5 year survival 82.8% 1-3 nodes- 5 year survival 73% 4-12 nodes- 5 year survival 46% >13 nodes- 5 year survival 28.4% Tumor size matters immediate and long term size correlates with axillary node status And is an independent prognostic indicator <1cm- 99% five year survival (88% 20 year recurrence free survival) 1-3 cm 89% (72% 20 year recurrence free survival) >3 cm 86% (59% 20 year recurrence-free survival

12 FACT #3 Screening mammography works Technological improvements have led to better detection

13 FACT #4 Detecting small tumors decreases mortality

14 Take home facts: Screening mammography is the only modality that is proven to save lives Best chances of surviving breast cancer is catching it early 1/8 women will have breast cancer sometime during their lifetime Of women that undergo screening mammography, about 6-8% will need additional evaluation, and 6-8% of those women will be diagnosised with breast cancer Of all the baseline screening exams, almost 1% will have breast cancer Non baseline screening exams, about 0.5% will have breast cancer Over the last 4 months OIC has diagnosised 13 breast cancers in asymptomatic women between years of age. All of our mammographers see every cancer that is diagnosised at OIC

15 ACR target statistics

16 RECOMMENDATIONS: THEN, NOW, AND TOMORROW

17 THEN: Screening recommendations Normal Risk Yearly Mammograms- starting at 40 years of age and continuing for as long as the patient is in good health Clinical breast exams, every three years from 20-40, yearly for patients >40 Monthly self breast exams

18 NOW: Screening recommendations Normal Risk Moderate Risk High Risk Yearly Mammogramsstarting at 40 years of age and continuing for as long as the patient is in good health Clinical breast exams, every three years from 20-40, yearly for patients >40 Monthly self breast exams NOW: recommendations are influenced by breast density, and personal/familial risk factors.

19 Family history Family history risk: Strong family history First degree w/ premenopausal Male relatives Known family history of BRCA genes Intermediate family history First degree w/ postmenopausal Weak family history Second degree relatives No family history

20 Family history of proven genetic cancer syndromes Li-fraumeni syndrome (p53 gene mutation) Sarcoma, breast, leukemia and adrenal gland (SBLA) syndrome Bannayan-Riley-Ruvalcaba syndrome (PTEN mutation) Cowden syndrome breast carcinoma, follicular carcinoma of the thyroid, and endometrial carcinoma (hamartomas everywhere)

21 Personal medical history History of XRT of chest for lymphoma History of Breast Cancer (IDC or ILC) Previous breast biopsies Atypical anything LCIS (50% multi ipse, 30% bilateral) 5-20% will be diagnosised with breast cancer within the next 5 years.

22 Mammographic breast density Not perceived density on breast exam. Proportion of breast composed of glandular elements and stoma seen at mammography

23 Mammographic breast density Senate bill 420 Effective January 1, 2014 Oregon became the 11 th state to pass breast density legislation requiring providers to inform women with dense breast tissue that they have dense breasts. This increases their risk of developing breast cancer Decreases the sensitivity of screening mammography The patient may need additional screening Failed to require the additional screening be covered by insurances intended to start a conversation between patients and their providers concerning if and what they need.

24 Required notification

25 Required notification

26

27 Case report Patient presents with confusion- I got a letter saying no breast cancer. But on the same letter, it says I have dense breasts so I might have cancer. And I was instructed to talk to you.

28 Reassure and risk stratify Risk stratify Risk model (like the Gail model) Take a detailed history

29 Personal breast cancer risk assessment Gail model, the Claus model, and the Tyrer- Cuzick model Give approximate estimates of breast cancer risk based on different combination of risk factors and different data sets May give different risk estimates for the same women Take home- Gail model is the best one currently- used for determining adjuvant hormonal therapy

30 Gail model The tool calculates a woman's risk of developing breast cancer within the next five years and within her lifetime (up to age 90). It takes into account seven key risk factors for breast cancer. Age Age at first period Age at the time of the birth of her first child (or has not given birth) Family history of breast cancer (mother, sister or daughter) Number of past breast biopsies Number of breast biopsies showing atypical hyperplasia Race/ethnicity Women with a five-year risk of 1.67 percent or higher are classified as "high-risk." This score (a five-year risk of 1.67 percent or higher) is the cut-off for the FDA guidelines for taking tamoxifen or raloxifene to reduce breast cancer risk. Limitations- based on white women, no paternal history), doesn t take into account personal history of DCIS, IDC, LCIS, or ILC

31 NOW: Screening recommendations Normal Risk (10-15%) Moderate Risk (15-20%) High Risk (>20%) High Risk and dense Yearly Mammogramsstarting at 40 years of age and continuing for as long as the patient is in good health Clinical breast exams, every three years from 20-40, yearly for patients >40 Monthly self breast exams NOW: recommendations are influenced by breast density, and personal/familial risk factors.

32 When is additional screening recommended? People at normal risk (10-15% lifetime risk)- No change CBE q3 years between ages CBE q1 year beginning at age 40 Screening digital mammography starting at age 40 Yearly, for as long as the patient is in moderately good health.

33 Patients at moderate risk 15-20% lifetime risk. Would additionally screen with bilateral whole breast US Dense breasts with elastography Previous biopsy results of LCIS, atypical anything Intermediate family history and heterogeneously dense breasts

34 Additional Screening with Whole breast US Is elastography important- yes What screening interval? Is this covered by insurance? Is this done else where in the world?

35 Patients at high risk >20% lifetime risk. Strongly consider additional breast MRI Personal or family history of genetically proven cancer syndrome (BRCA/p53/PTEN) Strong family history (1 st degree w/ premenpasual disease, or male relatives) Previous mediastinal XRT (starting 10 years after cessation of mediastinal XRT) Previous breast cancer (IDC or ILC)

36 Additional screening with Breast MRI Best done at a facility that also does breast biopsies. Or the patient may ultimately get billed for an additional breast MRI.

37 Low Risk (10-15%) Intermediate Risk (15-20%) High Risk (>20%) High risk and dense Family History No family history, a few 2 nd degrees 1 st degree post Multi 2 nd degrees 1 st degree w/ pre male Carrier/possible carrier of proven cancer syn. Personal history of: Breast Bx Atypical anything LCIS Mediastinal XRT Previous Breast CA (IDC or ILC) Breast Density (if dense breasts shift column to right) Extremely Dense or Heterogenou sly dense. Yearly dig Mammo with US at least q2 yr Yearly dig mammo And occ. MRI and occ. US Yearly dig mammo AND yearly MRI

38 TOMORROW: Screening recommendations?????? Digital genonmics, tomosynthesis, automated US

39 Questions Jonathan T. Sims

40 My patient received the letter stating she has dense breasts. Now she is wondering whether she should continue to get mammograms at all. She should continue to get screening mammograms. The breat density law does not reflect any change in the current mammography screening recommendations by professional medical societies. Mammograms have been shown to be effective in lowering breast cancer mortality for all breast densities.

41 My patient received the new breast density letter. She is concerned because she now thinks she is at high risk for breast cancer. Reassure the patient that breast density alone has only a small impact on breast cancer risk. She wants to know specifically how it changes her risk. Look up the mammogram report. Her density will be either heterogeneously dense (RR= 1.2), or extremely dense (RR= 2.0) So a 50 y/o female with no other risk factors fatty or scattered Risk is 1/42 50 y/o female with no risk factors and hetero, risk is 1.2/ y/o female with no risk factors and extememly dense, risk is 1/21.

42 My patient received the letter stating she has dense breasts. Now she wants to be screened with another modality instead of mammography. THERE IS NO MODALITY RECOMMENDED TO REPLACE MAMMOGRAPHY. Certain findings of cancer are ONLY seen on mammography. Other screening options referred to in the letter are in addition to, and not instead of, a routine screening mammogram.

43 My patient received the letter stating she has heterogneeously dense or extremely dense breasts. She has completed a risk assessment showing her overall risk to be high (>20% lifetime risk), or has a BRCA mutation or history of mantle radiation. Recommend annual breast MRI and annual memmogram for screening. Screening breast MRI is typically covered by insurance for high-risk women. If a woman is being screened annually with MRI and mammogram, no additional screening tests (such as ultrasound) are needed.

44 My patient received the letter stating she has heterogneeously dense or extremely dense breasts. She has completed a risk assessment showing her overall risk to be high (>20% lifetime risk). I recommended an annual MRI, but the patient has either claustrophobia, pacemaker, contrast allergy, limited insurance coverage plan, or other reasons why she does not want to have an MRI Recommend screening ultrasound as the second-best supplementary screening test for high risk women. Studies have shown some utility for ultrasound in high risk women if screening MRI is not performed.

Breast Imaging! Ravi Adhikary, MD!

Breast Imaging! Ravi Adhikary, MD! Breast Imaging! Ravi Adhikary, MD! ACS Estimated Cancers Statistics 2014! Breast! New Cases in Women! 232,670 (+67,570 in situ)! Deaths in Women! 40,000! Colon! 48,380! 24,040! Cervical! 12,360! 4,020!

More information

Evaluations & CE Credits

Evaluations & CE Credits Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. 1 Breast Density and Breast Cancer

More information

CLINICAL GUIDELINES. Screening Mammography Guidelines

CLINICAL GUIDELINES. Screening Mammography Guidelines CLINICAL GUIDELINES Screening Mammography Guidelines Paula George, M.D. and C. Todd Cunningham, M.D., Karen F. Goodhope, M.D., Valerie C. Reichert, M.D. Hayley Sheldon, M.D., Michelle Walters, D.O. 2/17/2016

More information

MANAGEMENT OF DENSE BREASTS. Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015

MANAGEMENT OF DENSE BREASTS. Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015 MANAGEMENT OF DENSE BREASTS Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015 No financial disclosures National Cancer Institute National Cancer Institute Increased Cancer Risk... DENSITY

More information

Breast density: imaging, risks and recommendations

Breast density: imaging, risks and recommendations Breast density: imaging, risks and recommendations Maureen Baxter, MD Radiologist Director of Ruth J. Spear Breast Center Providence St. Vincent Medical Center Alison Conlin, MD/MPH Medical Oncologist

More information

BREAST DENSITY WHAT IS IT? WHY IS IT IMPORTANT? & What IOWA SF250 Means to Patients and Providers

BREAST DENSITY WHAT IS IT? WHY IS IT IMPORTANT? & What IOWA SF250 Means to Patients and Providers BREAST DENSITY WHAT IS IT? WHY IS IT IMPORTANT? & What IOWA SF250 Means to Patients and Providers Arnold Honick, MD Radiology Consultants of Iowa, PLC ahonick@rciowa.com BREAST DENSITY LEGISLATION Nancy

More information

Tissue Breast Density

Tissue Breast Density Tissue Breast Density Reporting breast density within the letter to the patient is now mandated by VA law. Therefore, this website has been established by Peninsula Radiological Associates (PRA), the radiologists

More information

Breast Cancer Screening and High Risk

Breast Cancer Screening and High Risk Breast Cancer Screening and High Risk Mary Freyvogel, DO Breast Surgeon Clinical Assistant Professor of Surgery University Hospitals Case Medical Center St. John Medical Center / Elyria Medical Center

More information

Breast Cancer Imaging

Breast Cancer Imaging Breast Cancer Imaging I. Policy University Health Alliance (UHA) will cover breast imaging when such services meet the medical criteria guidelines (subject to limitations and exclusions) indicated below.

More information

Henda s Law. Supplemental screening for women with dense breast tissue and increased risk

Henda s Law. Supplemental screening for women with dense breast tissue and increased risk . Henda s Law Supplemental screening for women with dense breast tissue and increased risk The 2011 Texas Legislature passed House Bill 2102 which is effective 1st September 2011. The law is informally

More information

Improving the Identification of Underserved Women at High Risk for Breast Cancer and Increasing the use of Breast MRI Screening in this Population

Improving the Identification of Underserved Women at High Risk for Breast Cancer and Increasing the use of Breast MRI Screening in this Population Improving the Identification of Underserved Women at High Risk for Breast Cancer and Increasing the use of Breast MRI Screening in this Population Greenwood HI, Truong L, Price ER. UCSF Department or Radiology

More information

OBJECTIVES 8/25/2017. An attempt to organize the chaos

OBJECTIVES 8/25/2017. An attempt to organize the chaos High Risk for Breast Cancer and Genetics: Who? What? Where? When? An attempt to organize the chaos Presented at Winds of Change Conference November 3, 2017 by Carol Hager, MSN, CRNP and Allison Haener,

More information

Advances in Breast Cancer Diagnosis and Treatment. Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015

Advances in Breast Cancer Diagnosis and Treatment. Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015 Advances in Breast Cancer Diagnosis and Treatment Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015 Advances in Breast Cancer Diagnosis and Treatment Recommendations

More information

Imaging Guidelines for Breast Cancer Screening

Imaging Guidelines for Breast Cancer Screening Imaging Guidelines for Breast Cancer Screening Sarah Colwick, MD Dr. Sarah Colwick was born and raised in Sikeston, MO. She attended college and medical school at the University of Missouri-Kansas City

More information

Update in Breast Cancer Screening

Update in Breast Cancer Screening Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute and Grail - and - Karla Kerlikowske,

More information

Breast Cancer Risk Assessment and Prevention

Breast Cancer Risk Assessment and Prevention Breast Cancer Risk Assessment and Prevention Katherine B. Lee, MD, FACP October 4, 2017 STATISTICS More than 252,000 cases of breast cancer will be diagnosed this year alone. About 40,000 women will die

More information

Mammography and Other Screening Tests. for Breast Problems

Mammography and Other Screening Tests. for Breast Problems 301.681.3400 OBGYNCWC.COM Mammography and Other Screening Tests What is a screening test? for Breast Problems A screening test is used to find diseases, such as cancer, in people who do not have signs

More information

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Current Strategies in the Detection of Breast Cancer Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Outline ν Screening Film Mammography ν Film ν Digital ν Screening

More information

Screening Mammograms: Questions and Answers

Screening Mammograms: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Screening Mammograms:

More information

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Disclosure- I DO NOT HAVE any relevant financial interest with any entity producing,

More information

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014

Disclosures. Breast Cancer. Breast Imaging Modalities. Breast Cancer Screening. Breast Cancer 6/4/2014 : Information for the Primary Care Physician Disclosures No financial relationships with commercial entities producing health care products/services. Roxsann Roberts, MD Section Chief, MRI Erlanger/EmCare

More information

Camelia Davtyan, MD, FACP Clinical Professor of Medicine Director of Women s Health UCLA Comprehensive Health Program

Camelia Davtyan, MD, FACP Clinical Professor of Medicine Director of Women s Health UCLA Comprehensive Health Program Camelia Davtyan, MD, FACP Clinical Professor of Medicine Director of Women s Health UCLA Comprehensive Health Program A B C D USPSTF recommends the service. There is high certainty that Offer or provide

More information

Breast Cancer Screening and Diagnosis

Breast Cancer Screening and Diagnosis Breast Cancer Screening and Diagnosis Priya Thomas, MD Assistant Professor Clinical Cancer Prevention and Breast Medical Oncology University of Texas MD Anderson Cancer Center Disclosures Dr. Thomas has

More information

Increased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017

Increased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017 Increased Risk of Breast Cancer: Screening and Prevention Elizabeth Pritchard, MD 4/5/2017 No disclosures Defining Risk Risk Factors Modifiable Lifestyle obesity physical activity alcohol consumption breast

More information

Current Status of Supplementary Screening With Breast Ultrasound

Current Status of Supplementary Screening With Breast Ultrasound Current Status of Supplementary Screening With Breast Ultrasound Stephen A. Feig, M.D., FACR Fong and Jean Tsai Professor of Women s Imaging Department of Radiologic Sciences University of California,

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO 08/24/2012 Section: Surgery Place(s) of Service: Inpatient I.

More information

Foundational funding sources allow BCCHP to screen and diagnose women outside of the CDC guidelines under specific circumstances in Washington State.

Foundational funding sources allow BCCHP to screen and diagnose women outside of the CDC guidelines under specific circumstances in Washington State. Program Description The Breast, Cervical and Colon Health Program (BCCHP) screens qualifying clients for breast cancer. The program is funded through a grant from the Centers for Disease Control and Prevention

More information

Update in Breast Cancer Screening

Update in Breast Cancer Screening Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute - and - Karla Kerlikowske, MD

More information

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

IN THE COUNCIL OF THE DISTRICT OF COLUMBIA

IN THE COUNCIL OF THE DISTRICT OF COLUMBIA 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 A BILL 22-960 IN THE COUNCIL OF THE DISTRICT OF COLUMBIA To require health care facilities to notify patients of mammogram results

More information

Armed Forces Institute of Pathology.

Armed Forces Institute of Pathology. Armed Forces Institute of Pathology www.radpath.com Armed Forces Institute of Pathology Breast Disease www.radpath.org Armed Forces Institute of Pathology Interpretation of Breast MRI Leonard M. Glassman

More information

6 OBG Management August 2015 Vol. 27 No. 8 obgmanagement.com

6 OBG Management August 2015 Vol. 27 No. 8 obgmanagement.com Dense breasts are composed of a lot of fibrous and glandular tissue, with less adipose tissue. Heterogeneously dense and extremely dense breast tissue (as illustrated here) make it difficult to detect

More information

Breast Cancer. Dr. Andres Wiernik 2017

Breast Cancer. Dr. Andres Wiernik 2017 Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk

More information

Breast Density and Breast Tomosynthesis. How have they changed our lives?

Breast Density and Breast Tomosynthesis. How have they changed our lives? Breast Density and Breast Tomosynthesis How have they changed our lives? Renee W. Pinsky, MD Associate Professor of Radiology University of Michigan The only thing that is constant is change Heraclitus

More information

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic Evaluation & Management of PowerPoint Cover Title the High Risk Population High Risk Clinic Subtitle Joanna Would Springman, Go Here PA-C Assessment Genetics Known genetic mutation Family history with

More information

Screening Mammography: Who, what, where, when, why and how?

Screening Mammography: Who, what, where, when, why and how? Screening Mammography: Who, what, where, when, why and how? Jillian Lloyd, MD, MPH Breast Surgical Oncologist University Surgical Oncology Department of Surgery University of Tennessee Medical Center Disclosures

More information

Risk Assessment and Risk Management

Risk Assessment and Risk Management Risk Assessment and Risk Management Epworth Benign Breast Disease Symposium Dr Laura Chin-Lenn 12 November 2016 Why identify those at increased risk of breast cancer? Should I be worried? 1 Why identify

More information

High Risk Screening: A Multimodality Approach

High Risk Screening: A Multimodality Approach High Risk Screening: A Multimodality Approach John Lewin, M.D., FACR, FSBI The Women s Imaging Center Denver, Colorado Disclosures Consultant to Hologic Previously received research funds from Hologic

More information

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. Conni Murphy, ARNP Cancer Risk Assessment and Genetics Program Jupiter Medical Center Learning Objectives Identify

More information

Risk Assessment, Genetics, and Prevention

Risk Assessment, Genetics, and Prevention Risk Assessment, Genetics, and Prevention Katherine D. Crew, MD MS Director, Clinical Breast Cancer Prevention Program Columbia University Medical Center 1 Outline Breast cancer risk factors Hereditary

More information

Breast density. Understand what it is and why it matters

Breast density. Understand what it is and why it matters Breast density Understand what it is and why it matters What is breast density? Breasts are composed of fibrous, glandular and fatty tissues. Breast density is a term that refers to the proportion of these

More information

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary?

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? May 16, 2016 Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? Presenter: Emily Kuchinsky, MS, CGC 1 Experiences with Genetic Testing Adverse Events in Cancer Genetic Testing:

More information

Breast Density It's the Law

Breast Density It's the Law Last year Iowa became the 30th state in the last 12 years to require that density information be added to the written mammogram report to the patient. This report is sent directly from the interpreting

More information

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR ORIGINAL ARTICLE CLINICAL PRACTICE MANAGEMENT Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR Debra L. Monticciolo, MD a, Mary S. Newell, MD b, Linda Moy, MD

More information

Breast Density: Significance and Notification. Carol H. Lee Memorial Sloan-Kettering Cancer Center New York, NY

Breast Density: Significance and Notification. Carol H. Lee Memorial Sloan-Kettering Cancer Center New York, NY Breast Density: Significance and Notification Carol H. Lee Memorial Sloan-Kettering Cancer Center New York, NY Significance of Breast Density Association with increased risk for breast cancer Decreased

More information

Current issues and controversies in breast imaging. Kate Brown, South GP CME 2015

Current issues and controversies in breast imaging. Kate Brown, South GP CME 2015 Current issues and controversies in breast imaging Kate Brown, South GP CME 2015 JUDICIOUS USE OF RESOURCES IN REFERRALS FOR BREAST IMAGING THE DILEMMA How do target referrals for breast imaging? Want

More information

Challenges to Delivery of High Quality Mammography

Challenges to Delivery of High Quality Mammography Challenges to Delivery of High Quality Mammography Overview of Current Challenges Barbara Monsees, Washington University Geographic Access, Equity and Impact on Quality Tracy Onega, Dartmouth Medical School

More information

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia

What s New in Breast Imaging. Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia What s New in Breast Imaging Jennifer A. Harvey, M.D., FACR Professor of Radiology University of Virginia Disclosure Hologic, Inc. Shareholder and research agreement. Volpara Solutions, Ltd. Shareholder

More information

Screening for Breast Cancer

Screening for Breast Cancer Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final

More information

Breast Cancer. American Cancer Society

Breast Cancer. American Cancer Society Breast Cancer American Cancer Society Reviewed February 2017 What we ll be talking about How common is breast cancer? What is breast cancer? What causes it? What are the risk factors? Can breast cancer

More information

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team NATIONAL CLINICAL PRACTICE GUIDELINE Breast Cancer Screening Clinical Practice Guideline Kaiser Permanente National Breast Cancer Screening Guideline Development Team This guideline is informational only.

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO 07/22/2011 Section: Surgery Place(s) of Service: Inpatient I.

More information

2017 Breast Cancer Update

2017 Breast Cancer Update 2017 Breast Cancer Update Alberto J Montero, M.D., MBA Quality Improvement Officer, Taussig Cancer Institute, Lerner College of Medicine Cleveland Clinic N/A Disclosure Overview Epidemiology (US/Global)

More information

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Cancer Types Rev. 10.20.15 Page 19 Breast Cancer Group Discussion True False Not Sure 1. Breast cancer is not

More information

BREAST CANCER SCREENING IS A CHOICE

BREAST CANCER SCREENING IS A CHOICE BREAST CANCER SCREENING IS A CHOICE by ELAINE SCHATTNER, MD no financial disclosures (ES) American Association for Cancer Research Typical headlines focus on controversy 2 Data: Breast Cancer Incidence

More information

TMIST: Frequently Asked Questions

TMIST: Frequently Asked Questions TMIST: Frequently Asked Questions Key Topics for Site Investigators and Staff This document answers frequently asked questions about the Tomosynthesis Mammographic Imaging Screening Trial (TMIST/EA1151);

More information

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases

More information

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000

More information

TAKING CHARGE: SHARSHERET CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW. Wednesday, July 8, 2015

TAKING CHARGE: SHARSHERET CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW. Wednesday, July 8, 2015 Sharsheret 2015 SHARSHERET TAKING CHARGE: CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW Wednesday, July 8, 2015 To listen to the presentation by phone, Dial: 866-952-1906 Code: SHARSHERET Sharsheret

More information

Melissa Hartman, DO Women s Health Orlando VA Medical Center

Melissa Hartman, DO Women s Health Orlando VA Medical Center Melissa Hartman, DO Women s Health Orlando VA Medical Center Most common non-skin cancer and Second deadliest cancer in women Majority are diagnosed by abnormal screening study An approach to breast cancer

More information

Breast Cancer. Saima Saeed MD

Breast Cancer. Saima Saeed MD Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast

More information

Detection to Prediction: Imaging Markers of Breast Cancer Risk

Detection to Prediction: Imaging Markers of Breast Cancer Risk Detection to Prediction: Imaging Markers of Breast Cancer Risk Carrie B. Hruska, PhD, DABR Associate Professor of Medical Physics Mayo Clinic, Rochester, MN 2017 MFMER slide-1 Disclosure Per agreement

More information

Dense Breasts. A Breast Cancer Risk Factor and Imaging Challenge

Dense Breasts. A Breast Cancer Risk Factor and Imaging Challenge Dense Breasts A Breast Cancer Risk Factor and Imaging Challenge Renee Pinsky, MD University of Michigan Department of Radiology Division of Breast Imaging No Disclosures QUIZ: ARE YOU DENSE? a. Breast

More information

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue The New England Comparative Effectiveness Public Advisory Council Public Meeting December 13, 2013 The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography

More information

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow Debra A. Walz, RN, MS, AOCNP, WHNP-BC, RNFA Advanced Oncology & Women s Health Nurse Practitioner Oneida

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

5/24/16. Current Issues in Breast Cancer Screening. Breast cancer screening guidelines. Outline

5/24/16. Current Issues in Breast Cancer Screening. Breast cancer screening guidelines. Outline Disclosure information: An Evidence based Approach to Breast Cancer Karla Kerlikowske, MDDis Current Issues in Breast Cancer Screening Grant/Research support from: National Cancer Institute - and - Karla

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue

The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue TITLE: AUTHORS: The Comparative Clinical Effectiveness and Value of Supplemental Screening Tests Following Negative Mammography in Women with Dense Breast Tissue Jeffrey A. Tice, MD Associate Professor

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 09/01/2015 Section: Surgery Place(s) of Service:

More information

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD Non-mass Enhancement on Breast MRI Aditi A. Desai, MD Margaret Ann Mays, MD Breast MRI Important screening and diagnostic tool, given its high sensitivity for breast cancer detection Breast MRI - Indications

More information

Prophylactic Mastectomy

Prophylactic Mastectomy Prophylactic Mastectomy Policy Number: Original Effective Date: MM.06.010 01/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/01/2013 Section: Surgery Place(s) of Service:

More information

The Dilemma of Breast Density in Screening

The Dilemma of Breast Density in Screening The Dilemma of Breast Density in Screening Priscilla J. Slanetz MD, MPH, FACR, FSBI Associate Professor of Radiology, Harvard Medical School Beth Israel Deaconess Medical Center, Boston, MA No financial

More information

FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2

FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2 FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2 77053 Mammary ductogram or galactogram, single duct, Global Fee $59.05 May be billed with 77055, G0206, 77056, G0204, 76641, 76642 Billable

More information

SCREENING FOR BREAST CANCER BREAST IMAGING

SCREENING FOR BREAST CANCER BREAST IMAGING SCREENING FOR BREAST CANCER BREAST IMAGING Liane Philpotts, MD, FSBI, FACR Professor, Radiology and Biomedical Imaging Division Chief, Breast Imaging Dec. 5, 2017 Warner, E. NEJM 2011 Screening for

More information

Greater Sacramento Chapter Oncology Nursing Society Newsletter

Greater Sacramento Chapter Oncology Nursing Society Newsletter W I N T E R 2 0 1 4 / 2 0 1 5 Greater Sacramento Chapter Oncology Nursing Society Newsletter Hello GSCONS Membership, It is that time of year for our chapter to get ready for elections to the board. We

More information

Breast Imaging & You

Breast Imaging & You Breast Imaging & You What s Inside: Breast Imaging... 2 Digital Breast Tomosynthesis (DBT) mammograms... 4 Breast cancer screening... 6 Dense breast tissue... 8 Automated Breast Ultrasound (ABUS)... 9

More information

Frequently Asked Questions about Breast Density, Breast Cancer Risk, and the Breast Density Notification Law in California: A Consensus Document

Frequently Asked Questions about Breast Density, Breast Cancer Risk, and the Breast Density Notification Law in California: A Consensus Document RSNA, 2013 Appendix E1 Frequently Asked Questions about Breast Density, Breast Cancer Risk, and the Breast Density Notification Law in California: A Consensus Document 1. I have been getting more questions

More information

Breast Cancer: Selected Topics for the Primary Care Clinician

Breast Cancer: Selected Topics for the Primary Care Clinician Breast Cancer: Selected Topics for the Primary Care Clinician Leah Karliner, MD MAS October 2009 Primary Care Medicine: Principles and Practice OUTLINE Incidence and Mortality Risk Factors and Risk Reduction/Prevention

More information

High Risk or High Reward: Breast Cancer Prevention and Screening in Primary Care: New Challenges and Opportunities

High Risk or High Reward: Breast Cancer Prevention and Screening in Primary Care: New Challenges and Opportunities High Risk or High Reward: Breast Cancer Prevention and Screening in Primary Care: New Challenges and Opportunities Section 1 Jamie Stern, MD, MPH: Mammography in the 40s and 50s: the Data and the Controversy

More information

Breast Cancer Screening

Breast Cancer Screening Scan for mobile link. Breast Cancer Screening What is breast cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease

More information

Breast MRI: Friend or Foe?

Breast MRI: Friend or Foe? Breast MRI: Friend or Foe? UCSF Postgraduate Course May 18, 2013 Cheryl Ewing, MD Clinical Professor of Surgery UCSF Department of Surgery APPLEGATE HAS DOUBLE MASTECTOMY IN CANCER SCARE DIAGNOSED WITH

More information

WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016

WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016 WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016 39 th Annual CANP Educational Conference March 17 20, 2016 Collaborate. Educate. Advocate. Karen Herold, DNP,

More information

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of

More information

Screening Options in Dense Breasts. Donna Plecha, M.D. Co-Director UHCMC Breast Centers Associate Professor of Radiology Director of Breast Imaging

Screening Options in Dense Breasts. Donna Plecha, M.D. Co-Director UHCMC Breast Centers Associate Professor of Radiology Director of Breast Imaging Screening Options in Dense Breasts Donna Plecha, M.D. Co-Director UHCMC Breast Centers Associate Professor of Radiology Director of Breast Imaging Dense Breasted Women Decreased sensitivity of mammography

More information

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Disclosures Merck Nexplanon trainer Session Objectives Explain the rationale for initiation and frequency

More information

Breast Cancer. Common kinds of breast cancer are

Breast Cancer. Common kinds of breast cancer are Breast Cancer A breast is made up of three main parts: glands, ducts, and connective tissue. The glands produce milk. The ducts are passages that carry milk to the nipple. The connective tissue (which

More information

Original Policy Date

Original Policy Date MP 7.01.06 Prophylactic Mastectomy Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index

More information

Breast Cancer Risk Factors 8/3/2014

Breast Cancer Risk Factors 8/3/2014 Breast Cancer Screening: Changing Philosophies in Educating Women and Teens Courtney Benedict CNM MSN Session Objectives Explain the rationale for initiation and frequency of clinical breast exams to clients

More information

ABSITE Review. RTC Conference Christina Bailey January 15, 2009

ABSITE Review. RTC Conference Christina Bailey January 15, 2009 ABSITE Review RTC Conference Christina Bailey January 15, 2009 How It s Broken Down? 220 questions Junior level (PGY 1 and 2) Exam 60% Basic Science 40% Clinical Management Senior Level (PGY 3-5) exam

More information

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine Overview Rationale for new imaging

More information

Insights and Updates in Breast Cancer. No Disclosures. Learning Objectives. Mountain States Cancer Conference 2017 Regina Jeanise Brown MD

Insights and Updates in Breast Cancer. No Disclosures. Learning Objectives. Mountain States Cancer Conference 2017 Regina Jeanise Brown MD Insights and Updates in Breast Cancer Mountain States Cancer Conference 2017 Regina Jeanise Brown MD 10/14/17 No Disclosures Learning Objectives Understand screening recommendations Understand the effectiveness

More information

Breast Cancer Prevention and Early Detection

Breast Cancer Prevention and Early Detection Breast Cancer Prevention and Early Detection What is breast cancer Breast cancer is a malignant tumor that starts in the cells of the breast. A malignant tumor is a group of cancer cells that can grow

More information

How often should I get a mammogram?

How often should I get a mammogram? How often should I get a mammogram? Ages 50-74 BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central

More information

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening Define Breast Cancer Screening Examine breast cancer trends, statistics, and death rates, and impact of screenings Discuss benefits and risks of screening Compare and contrast Screening Guidelines Optimal

More information

Supplemental Screening for Women with Dense Breast Tissue. Public Meeting December 13, 2013

Supplemental Screening for Women with Dense Breast Tissue. Public Meeting December 13, 2013 Supplemental Screening for Women with Dense Breast Tissue Public Meeting December 13, 2013 Agenda Meeting Convened 10am-10:15am Presentation of the Evidence and Voting Questions, Q&A 10:15am 11:15am Discussion

More information

Case 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care

Case 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care Leah Karliner, MD MAS University of California San Francisco Primary Care Medicine Update 2009 April 2009 Case 1 AR, a 60 year old African

More information

2/9/2015. The high prevalence of breast disease and breast cancer (i.e. the problem is in every OB/GYN office, every day)

2/9/2015. The high prevalence of breast disease and breast cancer (i.e. the problem is in every OB/GYN office, every day) Breast Cancer: What is the Gynecologist s Role in Detection, Management, and Surveillance? James W. Orr, Jr. M.D. FACOG, FACS Chair, Florida Board of Medicine Medical Director: Regional Cancer Center &

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening Eileen Rakovitch MD MSc FRCPC Sunnybrook Health Sciences Centre Medical Director, Louise Temerty Breast Cancer Centre LC Campbell Chair in Breast Cancer Research Associate Professor,

More information

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER

NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER NATIONAL GUIDELINE CLEARINGHOUSE (NGC) GUIDELINE SYNTHESIS SCREENING FOR BREAST CANCER Guidelines 1. American Cancer Society (ACS). (1) ACS guidelines for breast cancer screening: update 2003. (2) American

More information